PMBI and Coal India Limited sign MoU to provide high-quality generic medicines

Current Context: The Memorandum of Understanding (MoU) between the Pharmaceuticals and Medical Devices Bureau of India (PMBI) and Coal India Limited (CIL) was signed on September 17, 2024 in New Delhi.

• The signing took place in the presence of key officials, including Ravi Dadhich.
• Key Details:
• Objective: To provide high-quality generic medicines to the workforce and communities associated with Coal India through the establishment of Jan Aushadhi Kendras.
• Locations: These Kendras will be set up at various Coal India premises, including coal fields, selected hospitals, and other suitable locations.
• Benefits: The initiative aims to make generic medicines more accessible and affordable, helping workers, residents, and their families save on out-of-pocket medical expenses. It also aims to create employment opportunities for entrepreneurs in the project areas.

Question:

1 What was the primary objective of the MoU signed between the Pharmaceuticals and Medical Devices Bureau of India (PMBI) and Coal India Limited (CIL) on September 17, 2024?

• A) To promote the use of alternative medicine
• B) To provide high-quality generic medicines to Coal India’s workforce and communities
• C) To increase exports of pharmaceutical products from India
• D) To promote medical tourism in coalfield areas

Answer: B) The primary objective of the MoU between PMBI and CIL is to establish Jan Aushadhi Kendras, which will provide high-quality generic medicines at affordable prices to the workforce and communities associated with Coal India.